Abstract
Few biomarkers exist for early detection of vascular cognitive impairment. We examined whether the Hachinski Ischemic Scale (HIS) can predict dementia in elderly. We leveraged data of the Canadian Study of Health and Aging. First, we examined the association of HIS with incident dementia. Next, we compared HIS to apolipoprotein E (APOE ɛ4) in prediction of dementia. We trained the HIS and APOE ɛ4 models in the training dataset and used the trained models for dementia prediction in the validation dataset. A higher HIS level was associated with a higher odds of dementia (odds ratio=1.64, 95% confidence interval [CI]: 1.41 to 1.90, P<.001). Dementia discrimination of the HIS model was not different from the APOE ɛ4 model (area under the curve difference=0.002, 95% CI: -0.024 to 0.029, P=.857). The calibration of the HIS model was 13.7 (P=.091) and of the APOE ɛ4 model was 13.3 (P=.100). HIS may be used as a simple, inexpensive test to identify older adults at risk of developing dementia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Alzheimer's & dementia : the journal of the Alzheimer's Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
